Showing 3 posts of 3 posts found.

FDA greenlights its first therapy for advanced epithelioid sarcoma population

January 27, 2020
Sales and Marketing Cancer, Epizyme, FDA, Tazverik, pharma

The FDA has revealed the approval of its first therapy for the treatment of metastatic or locally advanced epithelioid sarcoma, …


Boehringer signs $300 million deal with Epizyme over epigenetic cancer treatment

November 16, 2018
Medical Communications Boehringer, Cancer, Epizyme, deal, oncology

German firm Boehringer Ingelheim and the Massachusetts-based biotech Epizyme have announced that they will collaborate on the development of novel, …


Epizyme shuts down failing lymphoma trial as FDA imposes clinical hold

August 3, 2018
Medical Communications, Research and Development Epizyme, FDA, lymphoma, pharma, tazemetostat

Epizyme’s Q2 financial results have been derailed by the company’s decision to terminate further Phase 2 development of its lead …

Latest content